Inventor

GENESTE HERVE

DE38 patents

⚠️ This page may combine multiple inventors who share the name “GENESTE HERVE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

GENESTE HERVE

ABBOTT GMBH & CO KG

Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing them

Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing them

Triazole compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor

Integrin receptors antagonists

N-[(piperazinyl)hetaryl]arylsulfonamide compounds

Integrin receptor ligands

Pyrimidin-2-one compounds and their use as dopamine D3 receptor ligands

Substituted oxindol derivatives and medicaments containing the same

Triazole compounds and the therapeutic use thereof

Integrin ligands

Substituted oxindole derivatives, medicaments containing said derivatives and use thereof

Pyridin-2-one compounds and their use as modulators of the dopamine D3 receptor

Pyrimidine compounds and use thereof

Keto lactam compounds and use thereof

GENESTE HERVE

Heterocyclic compounds as positive modulators of metabotropic glutamate receptor 2 (mGlu2 receptor)

Pyridin-2-one compounds and their use as modulators of the dopamine D3 receptor

Pyrimidine compounds and use thereof

Substituted oxindole derivatives and their use as vasopressin and/or oxytocin receptor ligands

Substituted N-heterocyclic compounds and their use as dopamine D3 receptor ligands

BRAJE WILFRIED

Small molecule potentiators of metabotropic glutamate receptors I

1,2,4,-triazin-3,5-dione compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor

Small molecule potentiators of metabotropic glutamate receptors

N-[piperazinyl hetaryl]arylsufonamide compounds with affinity for the dopamine D3 receptor

Tetrahydrobenzazepines and their use in he modulation of the dopamine D3 receptor

LUBISCH WILFRIED

Substituted oxindole derivatives, medicaments containing the latter and use thereof

Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing them

Substituted oxindole derivatives, medicaments containing the latter and use thereof

Substituted oxindole derivatives and medicaments containing the same

NETZ ASTRID

Substituted oxindole derivatives and their use as vasopressin receptor ligands

Substituted oxindole derivatives and their use as vasopressin receptor ligands

Carbamate-substituted oxindole derivatives and use thereof for the treatment of vasopressin-dependent diseases

ABBVIE DEUTSCHLAND

Fused (hetero)cyclic compounds as S1P modulators

Oxindole derivatives carrying an oxetane substituent and use thereof for treating vassopressin-related diseases

Oxindole derivatives carrying an oxetane substituent and use thereof for treating vasopressine-related diseases

OOST THORSTEN

Amidomethyl-substituted oxindole derivatives and the use thereof for the treatment of vasopressin-dependent illnesses

Substituted oxindole derivatives, medicaments containing said derivatives and use thereof

ABBVIE INC

Fused heterocyclic compounds as S1P modulators

HAUPT ANDREAS

4-piperazinyl-pyrimidine compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor